surmount-1 tirzepatide weight loss percent 72 weeks reduction over time in tirzepatide‐treated participants by early weight response: Post hoc analysis in SURMOUNT‐1 - Ard - 2025 - Diabetes, Obesity and Metabolism surmount-1 tirzepatide weight loss percent

SingleCare Blog

The added targets generally correlate with larger weight reductions in trials

Contact your doctor or seek emergency care if you experience: Severe abdominal pain: Especially if it persists and radiates to your back Signs of pancreatitis: Severe stomach pain with nausea and vomiting Severe dehydration: Inability to keep fluids down, dizziness when standing Allergic reactions: Rash, difficulty breathing, or swelling Signs of gallbladder problems: Severe pain in the upper right abdomen Sudden vision changes: This is characterized by rapid vision loss or changes Suicidal thoughts or mood changes: New or worsening depression or severe, unusual behavioral changes Dont hesitate to reach out to your healthcare provider with questions or concerns about side effects, even if they seem minor

Gentle pressure : After the injection, apply light pressure with a cotton swab to minimize bruising

[1] These results support a selective growth hormone response in that study

TD1 usually occurs acutely unless it is a continuation of TD2